Unknown NA INTERVENTIONAL 2-arm NCT03345966

Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic Study

Validation of Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic Study

Sponsor: Cairo University

Conditions Oral Squamous Cell Carcinoma

Interventions Bmi-1 antibody

Updated 6 times since 2017 Last updated: Nov 14, 2017 Started: Dec 1, 2017 Primary completion: Dec 31, 2018 Completion: Nov 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Oral Squamous Cell Carcinoma and is currently ongoing. Cairo University leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Dec 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Dec 2019 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Dec 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt